- Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?
-
Helm CW
- KMID: 2158795
- J Gynecol Oncol.
- 2015 Jan;26(1):1-2.
- doi: 10.3802/jgo.2015.26.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- An Unusual Case of Spontaneous Remission of Hodgkin's Disease after a Single Cycle of COPP-ABV Chemotherapy Followed by Infectious Complications
-
Bang S, Cheong JW, Yang WI, Hahn JS
- KMID: 1734079
- Yonsei Med J.
- 2005 Jun;46(3):425-430.
- doi: 10.3349/ymj.2005.46.3.425
Advanced Hodgkin's disease is usually treated with six or more cycles of combination chemotherapy. Spontaneous regression of the cancer is very rarely reported in patients with Hodgkin's disease. We present... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary non-Hodgkin's Lymphoma of the Bladder with Bone Marrow Involvement
-
Oh KC, Zang DY
- KMID: 759633
- Korean J Intern Med.
- 2003 Mar;18(1):40-44.
Involvement of the lower urinary tract by advanced non-Hodgkin's lymphoma (NHL) has been reported in up to 13% of cases, but primary NHL of the urinary bladder is very rare.... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin 's Lymphoma
-
Kim JG, Sohn SK, Kim DH, Baek JH, Park TI, Lee KB
- KMID: 1778563
- J Korean Med Sci.
- 2004 Dec;19(6):820-825.
- doi: 10.3346/jkms.2004.19.6.820
The main objectives of the current study were to evaluate the efficacy and safety of a CEOP-E regimen for patients with aggressive non-Hodgkin's lymphoma (NHL). Fifty-one consecutive patients with newly... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Cetuximab (Erbitux(R)) plus FOLFIRI for Irinotecan and Oxaliplatin-refractory Metastatic Colorectal Cancer
-
Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Lee SS, Kim MK, Sym SJ, Lee JS, Kang YK
- KMID: 1785796
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S98-S103.
- doi: 10.3346/jkms.2007.22.S.S98
We have evaluated the efficacy and safety of cetuximab plus FOLFIRI for irinotecan and oxaliplatin-refractory colorectal cancers. From September 2004 to February 2006, 31 patients with metastatic colorectal cancer were... -
- CITED
-
- Close
- SHARE
-
- Close
- Double Autologous Stem Cell Transplantation for Multiple Myeloma: A Korean Single Center Study
-
Ko OB, Kim S, Shim H, Lee JH, Ahn JM, Yoon SM, Jeon MH, Do IN, Lee SY, Kim YG, Kim SW, Kim SB, Kim SH, Lee JS, Kim W, Park CJ, Chi HS, Suh C
- KMID: 1782236
- Korean J Intern Med.
- 2005 Sep;20(3):237-242.
- doi: 10.3904/kjim.2005.20.3.237
BACKGROUND: Although high dose chemotherapy coupled with an autologous stem cell transplantation (ASCT) is widely accepted as effective therapy for multiple myeloma (MM), few reports are available in Korea, especially... -
- CITED
-
- Close
- SHARE
-
- Close
- Mediastinal Single Nodal Relapse of a Nasal Nk/T cell Lymphoma
-
Rhee KH, Hong SC, An JM, Huh J, Ryu JS, Lee JS, Suh C
- KMID: 1785628
- Korean J Intern Med.
- 2007 Sep;22(3):201-205.
- doi: 10.3904/kjim.2007.22.3.201
A nasal NK/T cell lymphoma is a very aggressive form of lymphoma. Patterns of relapse after treatment have not been systematically evaluated, and mediastinal nodal relapse at a primary site... -
- CITED
-
- Close
- SHARE
-
- Close
- ESHAP Salvage Therapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
-
Choi CW, Paek CW, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS
- KMID: 1127252
- J Korean Med Sci.
- 2002 Oct;17(5):621-624.
- doi: 10.3346/jkms.2002.17.5.621
The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine (ara-C), and cisplatin, has been shown to be active against refractory or relapsed non-Hodgkin's lymphoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Individualized Tumor Response Testing for Prediction of Response to Paclitaxel and Cisplatin Chemotherapy in Patients with Advanced Gastric Cancer
-
Kim JH, Lee KW, Kim YH, Lee KH, Oh DY, Kim J, Yang SH, Im SA, Choi SH, Bang YJ
- KMID: 1713950
- J Korean Med Sci.
- 2010 May;25(5):684-690.
- doi: 10.3346/jkms.2010.25.5.684
The purpose of our study was to determine the most accurate analytic method to define in vitro chemosensitivity, using clinical response as reference standard in prospective clinical trial, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
-
Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK
- KMID: 1785799
- J Korean Med Sci.
- 2007 Sep;22(Suppl):S115-S121.
- doi: 10.3346/jkms.2007.22.S.S115
This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Image-Guided Percutaneous Lipiodol-Pingyangmycin Suspension Injection Therapy for Sacral Chordoma
-
Huang D, Chen Y, Zeng Q, Wu R, Li Y
- KMID: 1711441
- Korean J Radiol.
- 2013 Oct;14(5):823-828.
- doi: 10.3348/kjr.2013.14.5.823
A 74-year-old man presented with a progressively worsening pain in sacrum and was diagnosed to have a sacral chordoma by biopsy in May, 2004. Percutaneous intratumoral injection with lipiodol-pingyangmycin suspension... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcomes with CHOP Chemotherapy in Adult Patients with Hemophagocytic Lymphohistiocytosis
-
Shin HJ, Chung JS, Lee JJ, Sohn SK, Choi YJ, Kim YK, Yang DH, Kim HJ, Kim JG, Joo YD, Lee WS, Sohn CH, Lee EY, Cho GJ
- KMID: 1786882
- J Korean Med Sci.
- 2008 Jun;23(3):439-444.
- doi: 10.3346/jkms.2008.23.3.439
The objective of the current study was to investigate the treatment outcomes for the use of cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP) chemotherapy in adult patients with hemophagocytic lymphohistiocytosis (HLH).... -
- CITED
-
- Close
- SHARE
-
- Close
- Epirubicin, Cisplatin, and Protracted Venous Infusion of 5-Fluorouracil for Advanced Gastric Carcinoma
-
Cho EK, Lee WK, Lim DY, Bang SM, Park DK, Park YH, Kwon OS, Choi DJ, Shin DB, Lee JH, Lee TH
- KMID: 1101549
- J Korean Med Sci.
- 2002 Jun;17(3):348-352.
- doi: 10.3346/jkms.2002.17.3.348
To evaluate the activity and safety of a combination chemotherapy with epirubicin, cisplatin, and a protracted venous infusion of 5-fluorouracil (ECF) in unresectable or metastatic gastric cancer, a phase II... -
- CITED
-
- Close
- SHARE
-
- Close
- Definitive Chemoradiotherapy with Capecitabine and Cisplatin in Patients with Esophageal Cancer: A Pilot Study
-
Lee SJ, Ahn BM, Kim JG, Sohn SK, Chae YS, Moon JH, Lee EB, Kim JC, Park IK, Jeon SW
- KMID: 1794417
- J Korean Med Sci.
- 2009 Feb;24(1):120-125.
- doi: 10.3346/jkms.2009.24.1.120
We aimed to evaluate the feasibility of concurrent chemoradiotherapy (CRT) with capecitabine and cisplatin in patients with squamous cell carcinoma of the esophagus. Eighteen patients with esophageal cancer were enrolled... -
- CITED
-
- Close
- SHARE
-
- Close
- Irinotecan, Continuous 5-Fluorouracil, and Low dose of Leucovorin (modified FOLFIRI) as First Line of Therapy in Recurrent or Metastatic Colorectal Cancer
-
Lee MA, Byun JH, Shim BY, Woo IS, Kang JH, Hong YS, Lee KS, Choi MG, Chang SK, Oh ST, Choi SI, Lee DS
- KMID: 1782231
- Korean J Intern Med.
- 2005 Sep;20(3):205-209.
- doi: 10.3904/kjim.2005.20.3.205
BACKGROUND: Irinotecan, in combination with 5-fluorouracil (5-FU) and a high dose of leucovorin (LV), known as FOLFIRI regimen, has shown activity in recurrent or metastatic colorectal cancer. Therefore, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
-
Yoon JH, Park JA, Kim EK, Kang HJ, Shin HY, Ahn HS
- KMID: 1779131
- J Korean Med Sci.
- 2009 Apr;24(2):281-288.
- doi: 10.3346/jkms.2009.24.2.281
Relapse is the major cause of treatment failure in acute lymphoblastic leukemia (ALL), yet there is no established treatment for relapsed ALL. To improve the induction remission rate, we modified... -
- CITED
-
- Close
- SHARE
-
- Close
- Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma
-
Yoo C, Kim S, Sohn BS, Kim JE, Yoon DH, Huh J, Lee DH, Kim SW, Lee JS, Suh C
- KMID: 1776612
- Korean J Intern Med.
- 2010 Sep;25(3):301-308.
- doi: 10.3904/kjim.2010.25.3.301
BACKGROUND/AIMS: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy (R-CHOP) has improved survival in patients with diffuse large B-cell lymphoma (DLBCL) and weakened the prognostic power of the international prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Outcome of Adult Acute Lymphocytic Leukemia with VPD (L) Regimen: analysis of Prognostic Factors
-
Park SR, Kim JH, Kim DY, Lee SH, Lee SY, Choi IS, Yoon SS, Park SY, Kim BG, Kim NK
- KMID: 759630
- Korean J Intern Med.
- 2003 Mar;18(1):21-28.
BACKGROUND: Because of the relative paucity of data regarding the clinical outcome in adult patients with acute lymphocytic leukemia (ALL) in Korea, we analyzed clinical courses in adult ALL patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
-
Han HS, Kim JS, Park JH, Jeon YK, Lee KW, Oh DY, Kim JH, Park SY, Im SA, Kim TY, Park IA, Bang YJ
- KMID: 1782015
- J Korean Med Sci.
- 2009 Oct;24(5):910-917.
- doi: 10.3346/jkms.2009.24.5.910
We evaluated the efficacy and safety of weekly paclitaxel plus trastuzumab as firs-tline chemotherapy in women with HER2-overexpressing metastatic breast cancer (MBC), and we investigated the prognostic factors including magnitude... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Hepatic Arterial Infusion of Fluorouracil with Leucovorin as Salvage Treatment for Refractory Liver Metastases from Colorectal Cancer
-
Lee HJ, Lee YS, Lee KW, Kim SY, Yoon CJ, Shin DY, Lee YG, Choi SY, Kang SG, Kang SB, Kim JH
- KMID: 1036155
- Korean J Intern Med.
- 2011 Mar;26(1):82-88.
- doi: 10.3904/kjim.2011.26.1.82
BACKGROUND/AIMS: Limited options remain for patients with metastatic colorectal cancer (CRC) after failure of standard systemic chemotherapy. Readministration of chemotherapeutic agents by hepatic arterial infusion (HAI) has the rationale of... -
- CITED
-
- Close
- SHARE
-
- Close
